MedTrace Logo

MedStar Diabetes Pathway Chart Reviews

NCT03442595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 826

Last updated 2020-10-20

Study results available
· View outcomes & findings →

Summary

The MedStar Diabetes Pathway (MDP) is transitioning into a clinical program offered at various MedStar sites. The MDP clinical team is reviewing the data collected during the pilot to improve the program and adapt it to various clinical settings in order to better serve the target patient population. It is imperative to continue reviewing patient clinical outcomes as the program expands in order to insure continuous quality improvement of the program. This will be achieved through chart reviews of patients receiving diabetes care via the MDP and comparison with patients received diabetes standard of care through their primary care physician.

Conditions

  • Type2 Diabetes Mellitus

Interventions

OTHER

Intensive diabetes education and medication management

Patients receive intensive knowledge based diabetes education and algorithm driven medication management over a period of 12 weeks.

Sponsors & Collaborators

  • Medstar Health Research Institute

    lead OTHER

Principal Investigators

  • Michelle F Magee, MD · Medstar Health Research Institute

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2018-12-31
Completion
2019-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03442595 on ClinicalTrials.gov